MARATTO

article · Vaccine

COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024

2026Open accessUniversity of Ghana

Abstract

COVID-19 vaccines may have prevented COVID-19-associated SARI hospitalizations in the first 6 months over the study period in Ghana, and a pattern of protective effective was observed, consistent with report from other settings, although effect estimates were imprecise.

Research topics

  • SARS-CoV-2 and COVID-19 Research
  • Immune responses and vaccinations
  • COVID-19 Clinical Research Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.vaccine.2026.128310

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.